The potential of chitosan in ocular drug delivery

This paper presents an overview of the potential of chitosan-based systems for improving the retention and biodistribution of drugs applied topically onto the eye. Besides its low toxicity and good ocular tolerance, chitosan exhibits favourable biological behaviour, such as bioadhesion- and permeabi...

Full description

Saved in:
Bibliographic Details
Published inJournal of pharmacy and pharmacology Vol. 55; no. 11; p. 1451
Main Authors Alonso, María José, Sánchez, Alejandro
Format Journal Article
LanguageEnglish
Published England 01.11.2003
Subjects
Online AccessGet more information

Cover

Loading…
Abstract This paper presents an overview of the potential of chitosan-based systems for improving the retention and biodistribution of drugs applied topically onto the eye. Besides its low toxicity and good ocular tolerance, chitosan exhibits favourable biological behaviour, such as bioadhesion- and permeability-enhancing properties, and also interesting physico-chemical characteristics, which make it a unique material for the design of ocular drug delivery vehicles. The review summarizes the techniques for the production of chitosan gels, chitosan-coated colloidal systems and chitosan nanoparticles, and describes their mechanism of action upon contact with the ocular mucosa. The results reported until now have provided evidence of the potential of chitosan gels for enhancing and prolonging the retention of drugs on the eye surface. On the other hand, chitosan-based colloidal systems were found to work as transmucosal drug carriers, either facilitating the transport of drugs to the inner eye (chitosan-coated colloidal systems containing indometacin) or their accumulation into the corneal/conjunctival epithelia (chitosan nanoparticles containing ciclosporin). Finally, the tolerance, toxicity and biodegradation of the carriers under evaluation were reviewed.
AbstractList This paper presents an overview of the potential of chitosan-based systems for improving the retention and biodistribution of drugs applied topically onto the eye. Besides its low toxicity and good ocular tolerance, chitosan exhibits favourable biological behaviour, such as bioadhesion- and permeability-enhancing properties, and also interesting physico-chemical characteristics, which make it a unique material for the design of ocular drug delivery vehicles. The review summarizes the techniques for the production of chitosan gels, chitosan-coated colloidal systems and chitosan nanoparticles, and describes their mechanism of action upon contact with the ocular mucosa. The results reported until now have provided evidence of the potential of chitosan gels for enhancing and prolonging the retention of drugs on the eye surface. On the other hand, chitosan-based colloidal systems were found to work as transmucosal drug carriers, either facilitating the transport of drugs to the inner eye (chitosan-coated colloidal systems containing indometacin) or their accumulation into the corneal/conjunctival epithelia (chitosan nanoparticles containing ciclosporin). Finally, the tolerance, toxicity and biodegradation of the carriers under evaluation were reviewed.
Author Alonso, María José
Sánchez, Alejandro
Author_xml – sequence: 1
  givenname: María José
  surname: Alonso
  fullname: Alonso, María José
  email: ffmjalon@usc.es
  organization: Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain. ffmjalon@usc.es
– sequence: 2
  givenname: Alejandro
  surname: Sánchez
  fullname: Sánchez, Alejandro
BackLink https://www.ncbi.nlm.nih.gov/pubmed/14713355$$D View this record in MEDLINE/PubMed
BookMark eNo1jrlOAzEURV0EkQVKWuQfGPDzmleiiE2KRBPqyCsxmoxHnhmk_D1BQHOvzi2O7pLMutJFQm6A3QEHuGeMc6HMOaXRM7L44eY8iDlZDsMnY8xorS_JHKQBIZRaENgdIu3LGLsx25aWRP0hj2WwHc0dLX5qbaWhTh80xDZ_xXq6IhfJtkO8_usVeX963G1emu3b8-vmYdt4qVE2CIlLbi1q4wMoSNJhRGUdt8IpXBuPSliHAgIKEfiageMiRpWSR6k1X5HbX28_uWMM-77mo62n_f93_g0fJkQD
CitedBy_id crossref_primary_10_1016_j_carbpol_2013_01_082
crossref_primary_10_1016_j_carbpol_2014_09_038
crossref_primary_10_1080_17425247_2020_1754396
crossref_primary_10_1002_jps_24380
crossref_primary_10_1016_j_ijpharm_2017_06_079
crossref_primary_10_4155_tde_2017_0088
crossref_primary_10_1208_s12249_021_02166_9
crossref_primary_10_1016_j_ijpharm_2019_118688
crossref_primary_10_1016_j_ajps_2013_09_002
crossref_primary_10_1002_pat_1856
crossref_primary_10_1007_s12325_008_0059_1
crossref_primary_10_3390_pharmaceutics14030470
crossref_primary_10_1016_j_molliq_2021_116655
crossref_primary_10_1016_j_nano_2009_02_003
crossref_primary_10_1111_j_1463_5224_2010_00835_x
crossref_primary_10_1016_j_ajps_2017_09_001
crossref_primary_10_26599_NBE_2024_9290081
crossref_primary_10_17352_2455_3492_000013
crossref_primary_10_1517_17425247_3_4_463
crossref_primary_10_1016_j_ijpharm_2015_08_100
crossref_primary_10_1016_j_ejpb_2010_02_006
crossref_primary_10_1016_j_jconrel_2009_06_018
crossref_primary_10_1007_s11307_010_0352_7
crossref_primary_10_1016_S1773_2247_10_50005_4
crossref_primary_10_1080_17458080_2013_822108
crossref_primary_10_1016_j_ddtec_2005_05_008
crossref_primary_10_1016_j_ejpb_2010_02_011
crossref_primary_10_1016_j_carbpol_2019_115356
crossref_primary_10_1016_j_pdpdt_2014_11_003
crossref_primary_10_1002_mabi_202200175
crossref_primary_10_1007_s13346_022_01152_3
crossref_primary_10_1016_j_jconrel_2021_06_011
crossref_primary_10_3109_09637486_2011_640310
crossref_primary_10_1248_bpb_29_1685
crossref_primary_10_1016_j_yrtph_2009_09_015
crossref_primary_10_1186_s40199_015_0132_7
crossref_primary_10_1080_09205063_2012_701549
crossref_primary_10_1016_j_biotechadv_2015_01_003
crossref_primary_10_3390_pharmaceutics14050893
crossref_primary_10_1134_S0965545X11040080
crossref_primary_10_3390_ijms151018040
crossref_primary_10_1089_jop_2011_0174
crossref_primary_10_3390_nano13162340
crossref_primary_10_1080_17425255_2020_1803278
crossref_primary_10_1163_156856207779116739
crossref_primary_10_1098_rsif_2009_0285_focus
crossref_primary_10_1116_1_1800353
crossref_primary_10_1016_j_jddst_2022_103936
crossref_primary_10_1080_00914037_2024_2368895
crossref_primary_10_1016_j_jconrel_2022_08_040
crossref_primary_10_1080_02652048_2018_1425750
crossref_primary_10_1016_j_ijbiomac_2017_07_128
crossref_primary_10_1080_03639040701657792
crossref_primary_10_1038_gt_2008_16
crossref_primary_10_1016_j_ejpb_2011_05_006
crossref_primary_10_1016_j_ejpb_2012_05_003
crossref_primary_10_1016_j_jssc_2018_08_036
crossref_primary_10_1016_j_heliyon_2024_e26616
crossref_primary_10_3390_ijms14047445
crossref_primary_10_1016_S1773_2247_12_50016_X
crossref_primary_10_1016_j_ijbiomac_2014_02_002
crossref_primary_10_1016_j_ijpharm_2021_120900
crossref_primary_10_1016_j_ijbiomac_2018_10_089
crossref_primary_10_2217_17435889_2_1_11
crossref_primary_10_2217_nnm_15_205
crossref_primary_10_1371_journal_pone_0012085
crossref_primary_10_3390_md16100373
crossref_primary_10_1016_j_ijbiomac_2023_126697
crossref_primary_10_1016_j_ejmech_2015_07_045
crossref_primary_10_1016_j_ijpharm_2005_03_027
crossref_primary_10_1002_mabi_201900001
crossref_primary_10_1089_jop_2017_0079
crossref_primary_10_1016_j_ejpb_2009_02_006
crossref_primary_10_53879_id_50_01_p0030
crossref_primary_10_1365_s10337_010_1563_4
crossref_primary_10_1177_00405175221106228
crossref_primary_10_1016_j_jtos_2017_06_001
crossref_primary_10_1088_0957_4484_20_22_225108
crossref_primary_10_1517_17425240802712590
crossref_primary_10_1016_j_ijbiomac_2016_04_070
crossref_primary_10_7243_2050_120X_2_7
crossref_primary_10_1016_j_reactfunctpolym_2012_08_016
crossref_primary_10_2147_IJN_S237314
crossref_primary_10_3390_molecules28041963
crossref_primary_10_1021_acsapm_0c00087
crossref_primary_10_1002_bip_23578
crossref_primary_10_3390_molecules26041195
crossref_primary_10_1002_admt_202300171
crossref_primary_10_1016_j_biomaterials_2011_12_034
crossref_primary_10_3390_nano12020186
crossref_primary_10_1002_ptr_2970
crossref_primary_10_3109_02652048_2013_805839
crossref_primary_10_1016_j_ijbiomac_2016_03_042
crossref_primary_10_1155_2013_653892
crossref_primary_10_1517_17425247_2011_542142
crossref_primary_10_1517_17425247_2_5_843
crossref_primary_10_4155_tde_11_20
crossref_primary_10_1016_j_mtbio_2024_101126
crossref_primary_10_1039_D0BM00532K
crossref_primary_10_1049_mna2_12174
crossref_primary_10_1002_app_34323
crossref_primary_10_1021_acs_jchemed_7b00902
crossref_primary_10_1111_j_2042_7158_2012_01587_x
crossref_primary_10_1016_j_addr_2009_07_019
crossref_primary_10_1080_17425247_2019_1597848
crossref_primary_10_1248_bpb_34_740
crossref_primary_10_1016_j_polymer_2012_05_027
crossref_primary_10_3109_10611860903398099
crossref_primary_10_1016_S1773_2247_06_50056_5
crossref_primary_10_2174_2211738511666230816090046
crossref_primary_10_1016_j_ejps_2021_106041
crossref_primary_10_1007_s00289_022_04443_4
crossref_primary_10_1002_adma_202302431
crossref_primary_10_1016_j_carres_2019_107891
crossref_primary_10_2478_afpuc_2023_0009
crossref_primary_10_3390_ijms241612976
crossref_primary_10_1080_1061186X_2017_1280809
crossref_primary_10_1016_j_foodchem_2012_11_097
crossref_primary_10_1016_j_msec_2014_09_004
crossref_primary_10_4236_anp_2015_43009
crossref_primary_10_3390_md13031519
crossref_primary_10_1134_S1027451012100102
crossref_primary_10_1186_s13036_024_00414_7
crossref_primary_10_1016_j_ijbiomac_2013_05_034
crossref_primary_10_1021_acsbiomaterials_3c01144
crossref_primary_10_1016_j_carbpol_2007_11_007
crossref_primary_10_3390_app11199336
crossref_primary_10_1007_s00417_010_1383_0
crossref_primary_10_3892_etm_2014_1839
crossref_primary_10_1016_j_addr_2009_11_026
crossref_primary_10_1016_j_jddst_2020_102075
crossref_primary_10_1089_jop_2015_0047
crossref_primary_10_1016_j_ejps_2014_07_013
crossref_primary_10_1007_s11094_018_1870_x
crossref_primary_10_1134_S1063774511070170
crossref_primary_10_1111_j_1525_1594_2005_29021_x
crossref_primary_10_3109_10837450903479988
crossref_primary_10_3390_bioengineering7030065
crossref_primary_10_3390_md15030060
crossref_primary_10_1517_17425247_2014_938045
crossref_primary_10_1016_j_jconrel_2014_04_043
crossref_primary_10_1016_j_jddst_2023_104885
crossref_primary_10_1039_C5TB00594A
crossref_primary_10_1016_j_addr_2017_04_001
crossref_primary_10_1002_jbm_b_32871
crossref_primary_10_1007_s12247_015_9224_7
crossref_primary_10_1163_156856209X410274
crossref_primary_10_1080_17425247_2019_1556257
crossref_primary_10_1021_cr030441b
crossref_primary_10_1016_j_xphs_2018_09_034
crossref_primary_10_1016_j_preteyeres_2010_08_002
crossref_primary_10_1097_ICL_0000000000000033
crossref_primary_10_1016_j_jconrel_2022_03_031
crossref_primary_10_1111_boc_201500011
crossref_primary_10_3109_10611860903450023
crossref_primary_10_1016_j_biomaterials_2006_11_028
crossref_primary_10_1007_s11095_013_1109_1
crossref_primary_10_1016_j_xjec_2018_04_002
crossref_primary_10_1016_j_jddst_2021_102561
crossref_primary_10_1016_j_ijpharm_2014_06_017
crossref_primary_10_1016_j_ijpharm_2024_124033
crossref_primary_10_1016_j_colsurfb_2010_09_010
crossref_primary_10_3390_polym10111221
crossref_primary_10_1039_C4TB02044H
crossref_primary_10_1371_journal_pntd_0011976
crossref_primary_10_1146_annurev_bioeng_071813_105206
crossref_primary_10_1016_j_ijbiomac_2024_132700
crossref_primary_10_3389_fddev_2023_1077253
crossref_primary_10_1016_j_ijbiomac_2015_11_070
crossref_primary_10_1586_17469899_3_3_325
crossref_primary_10_1017_S1431927619000448
crossref_primary_10_1016_j_ejps_2012_02_023
crossref_primary_10_3390_polysaccharides3030037
crossref_primary_10_1007_s13346_024_01527_8
crossref_primary_10_1080_1539445X_2011_586082
crossref_primary_10_1016_j_xphs_2016_09_019
crossref_primary_10_1016_j_jconrel_2021_09_022
crossref_primary_10_1080_02652048_2017_1321048
crossref_primary_10_3390_ma16052073
crossref_primary_10_3109_13880209_2014_935949
crossref_primary_10_1016_j_carbpol_2021_118999
crossref_primary_10_1016_j_jconrel_2005_12_013
crossref_primary_10_1016_j_radphyschem_2013_06_026
crossref_primary_10_1016_j_colsurfb_2012_10_056
crossref_primary_10_1021_acs_biomac_0c00381
crossref_primary_10_1016_j_prosdent_2023_10_005
crossref_primary_10_1002_app_27767
crossref_primary_10_1016_j_colsurfb_2015_10_036
crossref_primary_10_1016_j_matpr_2017_07_018
crossref_primary_10_1016_j_ijpharm_2004_10_026
crossref_primary_10_3109_03639045_2015_1070171
crossref_primary_10_1002_jbm_a_30668
crossref_primary_10_1016_S1773_2247_08_50075_X
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1211/0022357022476
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
ExternalDocumentID 14713355
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1CY
1OB
1OC
29L
31~
33P
3O-
3SF
3WU
4.4
50Y
50Z
52M
52O
52S
52T
52U
52V
52W
53G
5GY
5RE
5WD
702
7PT
8-0
8-1
8-3
8-4
8-5
8WZ
930
A01
A03
A6W
AABZA
AACZT
AAESR
AAEVG
AAHHS
AAONW
AAPGJ
AAPXW
AARHZ
AAUAY
AAVAP
AAWDT
AAYOK
AAZKR
ABCUV
ABJNI
ABLJU
ABNHQ
ABOCM
ABPQP
ABPTD
ABPVW
ABQNK
ABWST
ABXVV
ACBWZ
ACCFJ
ACFBH
ACFRR
ACGFO
ACGFS
ACIWK
ACMXC
ACPOU
ACPRK
ACUTJ
ACXQS
ACYHN
ACZBC
ADBBV
ADEOM
ADIPN
ADIZJ
ADKYN
ADMGS
ADQBN
ADVEK
ADXAS
ADZMN
AEEZP
AEIMD
AENEX
AEQDE
AEUQT
AFBPY
AFFNX
AFFZL
AFGKR
AFPWT
AFRAH
AFXAL
AFYAG
AFZJQ
AGMDO
AGQXC
AGUTN
AHMBA
AI.
AIAGR
AIURR
AIWBW
AJAOE
AJBDE
AJEEA
ALAGY
ALMA_UNASSIGNED_HOLDINGS
AMBMR
AMYDB
APJGH
AQDSO
ASPBG
ATGXG
ATUGU
AVNTJ
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BCRHZ
BDRZF
BEYMZ
BHBCM
BROTX
BRXPI
C45
CAG
CGR
COF
CS3
CUY
CVF
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DRFUL
DRMAN
DRSTM
DU5
EBS
ECM
EIF
EJD
EMOBN
F00
F01
F04
F5P
FECEO
FEDTE
FLUFQ
FOEOM
G-S
G.N
GODZA
H.X
H13
HF~
HVGLF
HZ~
KBUDW
KOP
KSI
KSN
L7B
LATKE
LH4
LITHE
LOXES
LP6
LP7
LSO
LUTES
LW6
LYRES
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
MY~
N04
N05
NF~
NNB
NOMLY
NPM
O66
O9-
OAUYM
OCZFY
OJZSN
OPAEJ
OVD
OWPYF
P2P
P2W
P2X
P2Z
P4D
PALCI
PQQKQ
Q.N
QB0
R.K
RIWAO
RJQFR
ROL
ROX
RX1
SUPJJ
TEORI
TMA
UB1
V8K
VH1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WVDHM
X7M
XG1
YCJ
ZGI
ZXP
ZZTAW
~IA
~WT
ID FETCH-LOGICAL-c4694-91f242aa967cd151f4b9e95ab2a3b5987c953ab931d933d2801b23ee5ffc94662
ISSN 0022-3573
IngestDate Tue Oct 15 23:33:24 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4694-91f242aa967cd151f4b9e95ab2a3b5987c953ab931d933d2801b23ee5ffc94662
OpenAccessLink https://academic.oup.com/jpp/article-pdf/55/11/1451/36780185/0022357022476.pdf
PMID 14713355
ParticipantIDs pubmed_primary_14713355
PublicationCentury 2000
PublicationDate November 2003
PublicationDateYYYYMMDD 2003-11-01
PublicationDate_xml – month: 11
  year: 2003
  text: November 2003
PublicationDecade 2000
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Journal of pharmacy and pharmacology
PublicationTitleAlternate J Pharm Pharmacol
PublicationYear 2003
SSID ssj0007666
Score 2.2679503
SecondaryResourceType review_article
Snippet This paper presents an overview of the potential of chitosan-based systems for improving the retention and biodistribution of drugs applied topically onto the...
SourceID pubmed
SourceType Index Database
StartPage 1451
SubjectTerms Administration, Topical
Biocompatible Materials
Chitin - analogs & derivatives
Chitosan
Cyclosporine - administration & dosage
Drug Delivery Systems
Eye - anatomy & histology
Humans
Title The potential of chitosan in ocular drug delivery
URI https://www.ncbi.nlm.nih.gov/pubmed/14713355
Volume 55
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEA6uXryI77fkIHtxq7TpK0fxwSIoe1jBmyRtIsraFl0v_npnkvSxoqJeSttA-vimk6-ZzDeEHEqukOZLL2cR80KRxl6qdOyFEZcSxotYmVyY65t4eBte3UV3bTFOk10ylcfZ-5d5Jf9BFc4Brpgl-wdkm07hBOwDvrAFhGH7a4yrcooLfiynxKBA-SrM6sXSrjDNX94ejnI1wfUXMyHcDhWtrH61lWKqWjHrZrr9dAKPULrcHhNbPxcYPLBh9maWxhz6BdjBu0ueeRIoiDAztcBcjl3HXZql_rbWSO0urapubRZ-x_lh0d8vvXJgvDL2Bp0habAlXzoIVc8GIj_Ef2Z7hZ9bP4lk10090ktSdHc3OGnjBuQktiHr-mmc1Crc1cnMPaGArOvn00-GIRvjZbLkoKGnFvIVMqeKVdIfOZgGdNxmzb0OaJ-OOpitER-aaWMXtNS0tgv6WFBrFxTtgtZ2sU5uLy_GZ0PPlcbwsjDmIQxRGriVEDxOshxImw7ho-ORkIFgMuJpkvGICcmZn3PG8gB4iAyYUpHWGVYUCDbIfFEWaovQQIsEaWHOVBZyGaUyQUWnPBBxIjVT22TTvor7yuqf3Ncvaefbll2y2NrTHlnQ8MGpfWBvU3lgsPkAfsE9vg
link.rule.ids 783
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+potential+of+chitosan+in+ocular+drug+delivery&rft.jtitle=Journal+of+pharmacy+and+pharmacology&rft.au=Alonso%2C+Mar%C3%ADa+Jos%C3%A9&rft.au=S%C3%A1nchez%2C+Alejandro&rft.date=2003-11-01&rft.issn=0022-3573&rft.volume=55&rft.issue=11&rft.spage=1451&rft_id=info:doi/10.1211%2F0022357022476&rft_id=info%3Apmid%2F14713355&rft_id=info%3Apmid%2F14713355&rft.externalDocID=14713355
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3573&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3573&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3573&client=summon